Patents by Inventor Philip Andrew Lowry

Philip Andrew Lowry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of synthetic cannabinoids
    Patent number: 10175258
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: January 8, 2019
    Assignee: RANDOX LABORATORIES LIMITED
    Inventors: Stephen Peter Fitzgerald, Paul John Innocenzi, Ivan Robert McConnell, Philip Andrew Lowry, Elouard Benchikh
  • Detection of synthetic cannabinoids
    Patent number: 9441033
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and RCS families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: September 13, 2016
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Detection of synthetic cannabinoids
    Patent number: 9434687
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: September 6, 2016
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Stephen Peter FitzGerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Detection of synthetic cannabinoids
    Patent number: 9435817
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the CP family. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: September 6, 2016
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Mephedrone detection
    Patent number: 9128108
    Abstract: The invention relates to an immunoassay method and kit for the detection and/or the determination of mephedrone, mephedrone metabolites and related compounds. The invention is underpinned by a novel antibody, derived from a novel immunogen, that is sensitive and binds to mephedrone, mephedrone metabolites and related compounds.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: September 8, 2015
    Assignee: Randox Laboratories Limted
    Inventors: Robert Ivan McConnell, Elouard Benchikh, Philip Andrew Lowry, Stephen Peter Fitzgerald
  • DETECTION OF SYNTHETIC CANNABINOIDS
    Publication number: 20150118763
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: November 7, 2014
    Publication date: April 30, 2015
    Inventors: STEPHEN PETER FITZGERALD, PAUL JOHN INNOCENZI, IVAN ROBERT McCONNELL, PHILIP ANDREW LOWRY, ELOUARD BENCHIKH
  • Detection of synthetic cannabinoids
    Patent number: 8906633
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: December 9, 2014
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Immunodetection and quantification of pyrazolopyrimidine sedatives
    Patent number: 8852953
    Abstract: The invention relates to novel immunogens, antibodies, methods and kits for use in immunoassays to detect and quantify zaleplon, metabolites of zaleplon and indiplon. These are the first described immunoassays for these compounds and have greater sensitivity than alternative analytical techniques.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: October 7, 2014
    Assignee: Randox Laboratories Ltd.
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Philip Andrew Lowry, Ivan Robert McConnell
  • Immunoassay with extended detection window
    Patent number: 8673652
    Abstract: The immunoassay method and kit are provided for the detection and/or the determination of zolpidem. The disclosure provides novel antibodies, derived from a novel immunogen, that are highly sensitive and bind to zolpidem and its main urinary metabolite [3-(2-N,N-dimethylamino-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid, enabling an extension of the detection window of zolpidem in individuals who have abused the drug, or have been victim of its side-effects or its criminal misuse.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: March 18, 2014
    Assignee: Randox Laboratories Limited
    Inventors: Stephen Peter Fitzgerald, Robert Ivan McConnell, Philip Andrew Lowry, Elouard Benchikh
  • Glutathione S-transferase omega 1 wild type specific antibody
    Patent number: 8617828
    Abstract: The invention relates to a novel antibody which binds to wild type (wt) Glutathione S-transferase Omega 1 (wtGSTO1) but not to mutant (mut) GSTO1 and methods and uses based on the antibody. The antibody is based on novel haptens and immunogens.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: December 31, 2013
    Assignee: Randox Laboratories Limited
    Inventors: Peter Stephen Fitzgerald, Ivan Robert McConnell, Philip Andrew Lowry, Elouard Benchikh
  • MULTI-ANALYTE MICROARRAYS USING TAG-SPECIFIC ANTIBODIES AND TAG-ANCHORED ANTIBODIES
    Publication number: 20130310277
    Abstract: The invention describes accurate and flexible methods and kits for conducting multi-analyte microarrays through the use of Tag-specific antibodies and analyte-specific Tag-anchored antibodies.
    Type: Application
    Filed: December 20, 2011
    Publication date: November 21, 2013
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Stephen Peter Fitzgerald, Elouard Benchikh, Ivan McConnell, Philip Andrew Lowry
  • Detection of Synthetic Cannabinoids
    Publication number: 20130196354
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and RCS families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: August 14, 2012
    Publication date: August 1, 2013
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Stephen Peter Fitzgerald, Paul John Innocenzi, Elouard Benchikh, Philip Andrew Lowry, Ivan Robert McConnell
  • MCPP immunoassay
    Patent number: 8476029
    Abstract: The invention describes a practical and robust multi-antibody approach to the sensitive immunodetection and determination of the drug of abuse m-chlorophenyl piperazine (mCPP). The invention also describes methods and kits for mCPP detection in an in vitro sample.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: July 2, 2013
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Detection of Synthetic Cannabinoids
    Publication number: 20130066053
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: August 14, 2012
    Publication date: March 14, 2013
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Stephen Peter Fitzberald, Ivan Robert McConnell, Paul John Innocenzi, Elouard Benchikh, Philip Andrew Lowry
  • Detection of Synthetic Cannabinoids
    Publication number: 20130065323
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the CP family. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: August 14, 2012
    Publication date: March 14, 2013
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Glutathione S-Transferase Omega 1 Wild Type Specific Antibody
    Publication number: 20120237947
    Abstract: The invention relates to a novel antibody which binds to wild type (wt) Glutathione S-transferase Omega 1 (wtGSTO1) but not to mutant (mut) GSTO1 and methods and uses based on the antibody. The antibody is based on novel haptens and immunogens.
    Type: Application
    Filed: March 15, 2012
    Publication date: September 20, 2012
    Inventors: Peter Stephen Fitzgerald, Ivan Robert McConnell, Philip Andrew Lowry, Elouard Benchikh
  • IMMUNODETECTION AND QUANTIFICATION OF PYRAZOLOPYRIMIDINE SEDATIVES
    Publication number: 20120208294
    Abstract: The invention relates to novel immunogens, antibodies, methods and kits for use in immunoassays to detect and quantify zaleplon, metabolites of zaleplon and indiplon. These are the first described immunoassays for these compounds and have greater sensitivity than alternative analytical techniques.
    Type: Application
    Filed: July 16, 2010
    Publication date: August 16, 2012
    Applicant: RANDOX LABORATORIES LTD.
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Philip Andrew Lowry, Ivan Robert Mcconnell
  • Detection of Synthetic Cannabinoids
    Publication number: 20120208213
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: December 20, 2011
    Publication date: August 16, 2012
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • ASPIRIN ASSAY
    Publication number: 20120164756
    Abstract: The invention describes a method for monitoring and detecting non-therapeutic, therapeutic and toxic concentrations of aspirin in individuals which uses the urinary salicylic acid to salicyluric acid ratio.
    Type: Application
    Filed: June 9, 2010
    Publication date: June 28, 2012
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Philip Andrew Lowry, Paul John Innocenzi, Ivan Robert McConnell
  • MCPP IMMUNOASSAY
    Publication number: 20120135434
    Abstract: The invention describes a practical and robust multi-antibody approach to the sensitive immunodetection and determination of the drug of abuse m-chlorophenyl piperazine (mCPP). The invention also describes methods and kits for mCPP detection in an in vitro sample.
    Type: Application
    Filed: May 26, 2010
    Publication date: May 31, 2012
    Applicant: RANDOX LABORATORIES LTD.
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell